NASDAQ:CTSO
Cytosorbents Corporation Stock News
$0.88
+0.0606 (+7.40%)
At Close: May 03, 2024
CytoSorbents Corporation (Nasdaq: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically
CytoSorbents to Report Q2 2020 Operating and Financial Results
10:00am, Tuesday, 28'th Jul 2020
CytoSorbents Corporation (CTSO), CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in crit
Why CytoSorbents Is Soaring 12% Today
04:31pm, Wednesday, 22'nd Jul 2020
Shares in CytoSorbents (NASDAQ: CTSO) are surging 12% higher at 11:30 a.m. EDT on Wednesday after the company announced it will offer 5.3 million shares to the public at $9.50 per share. The influx o
CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common Stock
11:22am, Wednesday, 22'nd Jul 2020
CytoSorbents Corporation (Nasdaq: CTSO) (the "Company"), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammati
Why CytoSorbents Stock Got Clobbered Today
07:48pm, Tuesday, 21'st Jul 2020
Shares of CytoSorbents (NASDAQ: CTSO) were getting clobbered on Tuesday, with the stock sinking 15.9% as of 3:14 p.m. EDT. The big decline came after the maker of blood purification technologies anno
Is Cytosorbents' (NASDAQ:CTSO) Share Price Gain Of 133% Well Earned?
11:15am, Tuesday, 21'st Jul 2020
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
CytoSorbents Provides Preliminary Q2 2020 Financial Results and Corporate Update
08:51pm, Monday, 20'th Jul 2020
CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patie
CytoSorbents Corporation Announces Proposed $40 Million Public Offering of Common Stock
08:26pm, Monday, 20'th Jul 2020
CytoSorbents Corporation (Nasdaq: CTSO) (the "Company") a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammatio
Stocks To Watch: Bank Earnings And SPAC Deals Blaze In
08:25am, Saturday, 11'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
/C O R R E C T I O N -- CytoSorbents Corporation/
11:00am, Wednesday, 08'th Jul 2020
CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patie
CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patie
Hedge Funds Have Never Been More Bullish On Cytosorbents Corp (CTSO)
04:27pm, Thursday, 25'th Jun 2020
In this article we will take a look at whether hedge funds think Cytosorbents Corp (NASDAQ:CTSO) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving i
CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patie
CTSO: Positive Implications of $2.9 Million STTR Phase III Contract
09:40am, Friday, 19'th Jun 2020
By M. Marin NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT Contract Validates Potential of HemoDefend Technology Cytosorbents (NASDAQ:CTSO) was awarded a Defense Health Agency Small Business Technolog
Coronavirus can set off a 'Cytokine Storm'. These drugs may calm it. - Times of India
09:28am, Friday, 12'th Jun 2020
This “cytokine storm” was once an arcane phenomenon familiar mainly to rheumatologists who study when and how the immune system’s safeguards fail.
